ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,906Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 944

$714K Total Retail Price of All Prescriptions

Rank: 63 out of 944

409 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 503 422 1 1
LISINOPRIL 434 389 2 3
AMLODIPINE BESYLATE 386 345 3 5
METFORMIN HCL 373 303 4 12
METOPROLOL TARTRATE 357 317 5 8
HYDROCHLOROTHIAZIDE 347 321 6 9
LEVOTHYROXINE SODIUM 302 263 7 2
PRAVASTATIN SODIUM 297 282 8 17
ATORVASTATIN CALCIUM 295 259 9 13
OMEPRAZOLE 289 219 10 4
METOPROLOL SUCCINATE 272 241 11 14
POTASSIUM CHLORIDE 228 217 12 15
LOSARTAN POTASSIUM 210 165 13 16
FOSINOPRIL SODIUM 210 174 13 205
FUROSEMIDE 205 193 15 6
SERTRALINE HCL 197 170 16 23
WARFARIN SODIUM 178 137 17 7
ZETIA 177 153 18 59
ATENOLOL 156 131 19 11
DOXAZOSIN MESYLATE 129 117 20 60
HYDROCODONE-ACETAMINOPHEN 129 101 S3 20 10
TRIAMTERENE-HCTZ 125 94 22 33
ADVAIR DISKUS 122 84 23 31
CRESTOR 118 118 24 28
JANUVIA 113 90 25 81
ALENDRONATE SODIUM 105 81 26 20
GABAPENTIN 105 86 26 18
CARVEDILOL 104 93 28 30
DIOVAN 99 82 29 38
TRAMADOL HCL 99 99 29 21
ALLOPURINOL 97 94 31 22
ZOLPIDEM TARTRATE 96 79 32 25
POLYETHYLENE GLYCOL 3350 94 51 33 41
CLONIDINE HCL 73 73 34 67
CHLORTHALIDONE 69 56 35 119
GLYBURIDE MICRONIZED 68 48 R 36 327
KLOR-CON M20 67 59 37 71
CYMBALTA 67 29 37 75
PREDNISONE 67 66 37 32
SYNTHROID 62 58 40 82
FLUOXETINE HCL 61 26 41 48
LIPITOR 61 51 41 91
FLUTICASONE PROPIONATE 60 40 43 40
GEMFIBROZIL 59 49 44 72
FAMOTIDINE 58 58 45 74
CLOPIDOGREL 54 53 46 36
ISOSORBIDE MONONITRATE ER 51 47 47 52
TAMSULOSIN HCL 50 50 48 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.